Rosmarinic acid modulates pathways such as VEGF (vascular endothelial growth factor) and AChE (acetylcholinesterase) inhibitory pathways [11,12,13], potentially preventing hypoxia-induced angiogenesis and related complications in conditions like glaucoma. The gene discussed is ACHE; the disease is glaucoma.